Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 3295 entries
Sorted by: Best Match Show Resources per page
GPla Polymorphisms Are Associated with Outcomes in Patients at High Cardiovascular Risk.

Frontiers in cardiovascular medicine

Rath D, Schaeffeler E, Winter S, Levertov S, Müller K, Droppa M, Stimpfle F, Langer HF, Gawaz M, Schwab M, Geisler T.
PMID: 28871283
Front Cardiovasc Med. 2017 Aug 21;4:52. doi: 10.3389/fcvm.2017.00052. eCollection 2017.

BACKGROUND: Platelet membrane glycoprotein receptors mediate thrombus formation. GP Ia/IIa is an essential platelet integrin receptor. Single-nucleotide polymorphisms (SNPs) of the GP Ia/IIa gene alter GP Ia/IIa expression; however, their influence on cardiovascular disease remains unclear. This study aimed...

Cite
Rath D, Schaeffeler E, Winter S, et al. GPla Polymorphisms Are Associated with Outcomes in Patients at High Cardiovascular Risk. Front Cardiovasc Med. 2017;4:52doi: 10.3389/fcvm.2017.00052.
Rath, D., Schaeffeler, E., Winter, S., Levertov, S., Müller, K., Droppa, M., Stimpfle, F., Langer, H. F., Gawaz, M., Schwab, M., & Geisler, T. (2017). GPla Polymorphisms Are Associated with Outcomes in Patients at High Cardiovascular Risk. Frontiers in cardiovascular medicine, 452. https://doi.org/10.3389/fcvm.2017.00052
Rath, Dominik, et al. "GPla Polymorphisms Are Associated with Outcomes in Patients at High Cardiovascular Risk." Frontiers in cardiovascular medicine vol. 4 (2017): 52. doi: https://doi.org/10.3389/fcvm.2017.00052
Rath D, Schaeffeler E, Winter S, Levertov S, Müller K, Droppa M, Stimpfle F, Langer HF, Gawaz M, Schwab M, Geisler T. GPla Polymorphisms Are Associated with Outcomes in Patients at High Cardiovascular Risk. Front Cardiovasc Med. 2017 Aug 21;4:52. doi: 10.3389/fcvm.2017.00052. eCollection 2017. PMID: 28871283; PMCID: PMC5566565.
Copy Download .nbib Format: NLM
Dicarbonyl Stress and Glyoxalase-1 in Skeletal Muscle: Implications for Insulin Resistance and Type 2 Diabetes.

Frontiers in cardiovascular medicine

Mey JT, Haus JM.
PMID: 30250846
Front Cardiovasc Med. 2018 Sep 10;5:117. doi: 10.3389/fcvm.2018.00117. eCollection 2018.

Glyoxalase-1 (GLO1) is a ubiquitously expressed cytosolic protein which plays a role in the natural maintenance of cellular health and is abundantly expressed in human skeletal muscle. A consequence of reduced GLO1 protein expression is cellular dicarbonyl stress, which...

Cite
Mey JT, Haus JM. Dicarbonyl Stress and Glyoxalase-1 in Skeletal Muscle: Implications for Insulin Resistance and Type 2 Diabetes. Front Cardiovasc Med. 2018;5:117doi: 10.3389/fcvm.2018.00117.
Mey, J. T., & Haus, J. M. (2018). Dicarbonyl Stress and Glyoxalase-1 in Skeletal Muscle: Implications for Insulin Resistance and Type 2 Diabetes. Frontiers in cardiovascular medicine, 5117. https://doi.org/10.3389/fcvm.2018.00117
Mey, Jacob T, and Haus, Jacob M. "Dicarbonyl Stress and Glyoxalase-1 in Skeletal Muscle: Implications for Insulin Resistance and Type 2 Diabetes." Frontiers in cardiovascular medicine vol. 5 (2018): 117. doi: https://doi.org/10.3389/fcvm.2018.00117
Mey JT, Haus JM. Dicarbonyl Stress and Glyoxalase-1 in Skeletal Muscle: Implications for Insulin Resistance and Type 2 Diabetes. Front Cardiovasc Med. 2018 Sep 10;5:117. doi: 10.3389/fcvm.2018.00117. eCollection 2018. PMID: 30250846; PMCID: PMC6139330.
Copy Download .nbib Format: NLM
Automatic Estimation of Coronary Blood Flow Velocity Step 1 for Developing a Tool to Diagnose Patients With Micro-Vascular Angina Pectoris.

Frontiers in cardiovascular medicine

Khanmohammadi M, Engan K, Sæland C, Eftestøl T, Larsen AI.
PMID: 30740396
Front Cardiovasc Med. 2019 Jan 22;6:1. doi: 10.3389/fcvm.2019.00001. eCollection 2019.

No abstract available.

Cite
Khanmohammadi M, Engan K, Sæland C, et al. Automatic Estimation of Coronary Blood Flow Velocity Step 1 for Developing a Tool to Diagnose Patients With Micro-Vascular Angina Pectoris. Front Cardiovasc Med. 2019;6:1doi: 10.3389/fcvm.2019.00001.
Khanmohammadi, M., Engan, K., Sæland, C., Eftestøl, T., & Larsen, A. I. (2019). Automatic Estimation of Coronary Blood Flow Velocity Step 1 for Developing a Tool to Diagnose Patients With Micro-Vascular Angina Pectoris. Frontiers in cardiovascular medicine, 61. https://doi.org/10.3389/fcvm.2019.00001
Khanmohammadi, Mahdieh, et al. "Automatic Estimation of Coronary Blood Flow Velocity Step 1 for Developing a Tool to Diagnose Patients With Micro-Vascular Angina Pectoris." Frontiers in cardiovascular medicine vol. 6 (2019): 1. doi: https://doi.org/10.3389/fcvm.2019.00001
Khanmohammadi M, Engan K, Sæland C, Eftestøl T, Larsen AI. Automatic Estimation of Coronary Blood Flow Velocity Step 1 for Developing a Tool to Diagnose Patients With Micro-Vascular Angina Pectoris. Front Cardiovasc Med. 2019 Jan 22;6:1. doi: 10.3389/fcvm.2019.00001. eCollection 2019. PMID: 30740396; PMCID: PMC6357931.
Copy Download .nbib Format: NLM
Higher Dispersion Measures of Conduction and Repolarization in Type 1 Compared to Non-type 1 Brugada Syndrome Patients: An Electrocardiographic Study From a Single Center.

Frontiers in cardiovascular medicine

Tse G, Li KHC, Li G, Liu T, Bazoukis G, Wong WT, Chan MTV, Wong MCS, Xia Y, Letsas KP, Chan GCP, Chan YS, Wu WKK.
PMID: 30338262
Front Cardiovasc Med. 2018 Oct 04;5:132. doi: 10.3389/fcvm.2018.00132. eCollection 2018.

No abstract available.

Cite
Tse G, Li KHC, Li G, et al. Higher Dispersion Measures of Conduction and Repolarization in Type 1 Compared to Non-type 1 Brugada Syndrome Patients: An Electrocardiographic Study From a Single Center. Front Cardiovasc Med. 2018;5:132doi: 10.3389/fcvm.2018.00132.
Tse, G., Li, K. H. C., Li, G., Liu, T., Bazoukis, G., Wong, W. T., Chan, M. T. V., Wong, M. C. S., Xia, Y., Letsas, K. P., Chan, G. C. P., Chan, Y. S., & Wu, W. K. K. (2018). Higher Dispersion Measures of Conduction and Repolarization in Type 1 Compared to Non-type 1 Brugada Syndrome Patients: An Electrocardiographic Study From a Single Center. Frontiers in cardiovascular medicine, 5132. https://doi.org/10.3389/fcvm.2018.00132
Tse, Gary, et al. "Higher Dispersion Measures of Conduction and Repolarization in Type 1 Compared to Non-type 1 Brugada Syndrome Patients: An Electrocardiographic Study From a Single Center." Frontiers in cardiovascular medicine vol. 5 (2018): 132. doi: https://doi.org/10.3389/fcvm.2018.00132
Tse G, Li KHC, Li G, Liu T, Bazoukis G, Wong WT, Chan MTV, Wong MCS, Xia Y, Letsas KP, Chan GCP, Chan YS, Wu WKK. Higher Dispersion Measures of Conduction and Repolarization in Type 1 Compared to Non-type 1 Brugada Syndrome Patients: An Electrocardiographic Study From a Single Center. Front Cardiovasc Med. 2018 Oct 04;5:132. doi: 10.3389/fcvm.2018.00132. eCollection 2018. PMID: 30338262; PMCID: PMC6180153.
Copy Download .nbib Format: NLM
Relevance of Multi-Omics Studies in Cardiovascular Diseases.

Frontiers in cardiovascular medicine

Leon-Mimila P, Wang J, Huertas-Vazquez A.
PMID: 31380393
Front Cardiovasc Med. 2019 Jul 17;6:91. doi: 10.3389/fcvm.2019.00091. eCollection 2019.

Cardiovascular diseases are the leading cause of death around the world. Despite the larger number of genes and loci identified, the precise mechanisms by which these genes influence risk of cardiovascular disease is not well understood. Recent advances in...

Cite
Leon-Mimila P, Wang J, Huertas-Vazquez A. Relevance of Multi-Omics Studies in Cardiovascular Diseases. Front Cardiovasc Med. 2019;6:91doi: 10.3389/fcvm.2019.00091.
Leon-Mimila, P., Wang, J., & Huertas-Vazquez, A. (2019). Relevance of Multi-Omics Studies in Cardiovascular Diseases. Frontiers in cardiovascular medicine, 691. https://doi.org/10.3389/fcvm.2019.00091
Leon-Mimila, Paola, et al. "Relevance of Multi-Omics Studies in Cardiovascular Diseases." Frontiers in cardiovascular medicine vol. 6 (2019): 91. doi: https://doi.org/10.3389/fcvm.2019.00091
Leon-Mimila P, Wang J, Huertas-Vazquez A. Relevance of Multi-Omics Studies in Cardiovascular Diseases. Front Cardiovasc Med. 2019 Jul 17;6:91. doi: 10.3389/fcvm.2019.00091. eCollection 2019. PMID: 31380393; PMCID: PMC6656333.
Copy Download .nbib Format: NLM
Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach.

Frontiers in cardiovascular medicine

Pastori D, Menichelli D, Gingis R, Pignatelli P, Violi F.
PMID: 30915342
Front Cardiovasc Med. 2019 Mar 12;6:17. doi: 10.3389/fcvm.2019.00017. eCollection 2019.

The management of antithrombotic therapy for thromboprophylaxis in patients with atrial fibrillation (AF) has been recently evolved by the progressive replacement of vitamin K antagonists with the non-vitamin K antagonist oral anticoagulants (NOACs). However, while these drugs are effective...

Cite
Pastori D, Menichelli D, Gingis R, et al. Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach. Front Cardiovasc Med. 2019;6:17doi: 10.3389/fcvm.2019.00017.
Pastori, D., Menichelli, D., Gingis, R., Pignatelli, P., & Violi, F. (2019). Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach. Frontiers in cardiovascular medicine, 617. https://doi.org/10.3389/fcvm.2019.00017
Pastori, Daniele, et al. "Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach." Frontiers in cardiovascular medicine vol. 6 (2019): 17. doi: https://doi.org/10.3389/fcvm.2019.00017
Pastori D, Menichelli D, Gingis R, Pignatelli P, Violi F. Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach. Front Cardiovasc Med. 2019 Mar 12;6:17. doi: 10.3389/fcvm.2019.00017. eCollection 2019. PMID: 30915342; PMCID: PMC6422871.
Copy Download .nbib Format: NLM
Neutrophils in Post-myocardial Infarction Inflammation: Damage vs. Resolution?.

Frontiers in cardiovascular medicine

Puhl SL, Steffens S.
PMID: 30937305
Front Cardiovasc Med. 2019 Mar 18;6:25. doi: 10.3389/fcvm.2019.00025. eCollection 2019.

Inflammation not only plays a crucial role in acute ischemic cardiac injury, but also contributes to post-infarction repair and remodeling. Traditionally, neutrophils have been merely considered as detrimental in the setting of an acute myocardial infarction. However, recently published...

Cite
Puhl SL, Steffens S. Neutrophils in Post-myocardial Infarction Inflammation: Damage vs. Resolution?. Front Cardiovasc Med. 2019;6:25doi: 10.3389/fcvm.2019.00025.
Puhl, S. L., & Steffens, S. (2019). Neutrophils in Post-myocardial Infarction Inflammation: Damage vs. Resolution?. Frontiers in cardiovascular medicine, 625. https://doi.org/10.3389/fcvm.2019.00025
Puhl, Sarah-Lena, and Steffens, Sabine. "Neutrophils in Post-myocardial Infarction Inflammation: Damage vs. Resolution?." Frontiers in cardiovascular medicine vol. 6 (2019): 25. doi: https://doi.org/10.3389/fcvm.2019.00025
Puhl SL, Steffens S. Neutrophils in Post-myocardial Infarction Inflammation: Damage vs. Resolution?. Front Cardiovasc Med. 2019 Mar 18;6:25. doi: 10.3389/fcvm.2019.00025. eCollection 2019. PMID: 30937305; PMCID: PMC6431642.
Copy Download .nbib Format: NLM
RNAs and RNA-Binding Proteins in Immuno-Metabolic Homeostasis and Diseases.

Frontiers in cardiovascular medicine

Salem ESB, Vonberg AD, Borra VJ, Gill RK, Nakamura T.
PMID: 31482095
Front Cardiovasc Med. 2019 Aug 20;6:106. doi: 10.3389/fcvm.2019.00106. eCollection 2019.

The increasing prevalence of worldwide obesity has emerged as a major risk factor for type 2 diabetes (T2D), hepatosteatosis, and cardiovascular disease. Accumulating evidence indicates that obesity has strong inflammatory underpinnings tightly linked to the development of metabolic diseases....

Cite
Salem ESB, Vonberg AD, Borra VJ, et al. RNAs and RNA-Binding Proteins in Immuno-Metabolic Homeostasis and Diseases. Front Cardiovasc Med. 2019;6:106doi: 10.3389/fcvm.2019.00106.
Salem, E. S. B., Vonberg, A. D., Borra, V. J., Gill, R. K., & Nakamura, T. (2019). RNAs and RNA-Binding Proteins in Immuno-Metabolic Homeostasis and Diseases. Frontiers in cardiovascular medicine, 6106. https://doi.org/10.3389/fcvm.2019.00106
Salem, Esam S B, et al. "RNAs and RNA-Binding Proteins in Immuno-Metabolic Homeostasis and Diseases." Frontiers in cardiovascular medicine vol. 6 (2019): 106. doi: https://doi.org/10.3389/fcvm.2019.00106
Salem ESB, Vonberg AD, Borra VJ, Gill RK, Nakamura T. RNAs and RNA-Binding Proteins in Immuno-Metabolic Homeostasis and Diseases. Front Cardiovasc Med. 2019 Aug 20;6:106. doi: 10.3389/fcvm.2019.00106. eCollection 2019. PMID: 31482095; PMCID: PMC6710452.
Copy Download .nbib Format: NLM
Chinese Herbal Medicine as a Potential Treatment of Abdominal Aortic Aneurysm.

Frontiers in cardiovascular medicine

Seto SW, Chang D, Kiat H, Wang N, Bensoussan A.
PMID: 29732374
Front Cardiovasc Med. 2018 Apr 20;5:33. doi: 10.3389/fcvm.2018.00033. eCollection 2018.

Abdominal aortic aneurysm (AAA) is an irreversible condition where the abdominal aorta is dilated leading to potentially fatal consequence of aortic rupture. Multiple mechanisms are involved in the development and progression of AAA, including chronic inflammation, oxidative stress, vascular...

Cite
Seto SW, Chang D, Kiat H, et al. Chinese Herbal Medicine as a Potential Treatment of Abdominal Aortic Aneurysm. Front Cardiovasc Med. 2018;5:33doi: 10.3389/fcvm.2018.00033.
Seto, S. W., Chang, D., Kiat, H., Wang, N., & Bensoussan, A. (2018). Chinese Herbal Medicine as a Potential Treatment of Abdominal Aortic Aneurysm. Frontiers in cardiovascular medicine, 533. https://doi.org/10.3389/fcvm.2018.00033
Seto, Sai Wang, et al. "Chinese Herbal Medicine as a Potential Treatment of Abdominal Aortic Aneurysm." Frontiers in cardiovascular medicine vol. 5 (2018): 33. doi: https://doi.org/10.3389/fcvm.2018.00033
Seto SW, Chang D, Kiat H, Wang N, Bensoussan A. Chinese Herbal Medicine as a Potential Treatment of Abdominal Aortic Aneurysm. Front Cardiovasc Med. 2018 Apr 20;5:33. doi: 10.3389/fcvm.2018.00033. eCollection 2018. PMID: 29732374; PMCID: PMC5919947.
Copy Download .nbib Format: NLM
Cell Phenotype Transitions in Cardiovascular Calcification.

Frontiers in cardiovascular medicine

Hortells L, Sur S, St Hilaire C.
PMID: 29632866
Front Cardiovasc Med. 2018 Mar 26;5:27. doi: 10.3389/fcvm.2018.00027. eCollection 2018.

Cardiovascular calcification was originally considered a passive, degenerative process, however with the advance of cellular and molecular biology techniques it is now appreciated that ectopic calcification is an active biological process. Vascular calcification is the most common form of...

Cite
Hortells L, Sur S, St Hilaire C. Cell Phenotype Transitions in Cardiovascular Calcification. Front Cardiovasc Med. 2018;5:27doi: 10.3389/fcvm.2018.00027.
Hortells, L., Sur, S., & St Hilaire, C. (2018). Cell Phenotype Transitions in Cardiovascular Calcification. Frontiers in cardiovascular medicine, 527. https://doi.org/10.3389/fcvm.2018.00027
Hortells, Luis, et al. "Cell Phenotype Transitions in Cardiovascular Calcification." Frontiers in cardiovascular medicine vol. 5 (2018): 27. doi: https://doi.org/10.3389/fcvm.2018.00027
Hortells L, Sur S, St Hilaire C. Cell Phenotype Transitions in Cardiovascular Calcification. Front Cardiovasc Med. 2018 Mar 26;5:27. doi: 10.3389/fcvm.2018.00027. eCollection 2018. PMID: 29632866; PMCID: PMC5879740.
Copy Download .nbib Format: NLM
Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction.

Frontiers in cardiovascular medicine

Naesgaard PA, Grundt H, Nordøy AF, Staines H, Nilsen DWT.
PMID: 28791297
Front Cardiovasc Med. 2017 Jul 24;4:41. doi: 10.3389/fcvm.2017.00041. eCollection 2017.

BACKGROUND: Fish is the natural dietary source of vitamin D. Reports on the influence of purified omega-3 fatty acids on its uptake are scarce.OBJECTIVES: We investigated the impact of a purified high-dose omega-3 compound compared to corn oil on...

Cite
Naesgaard PA, Grundt H, Nordøy AF, et al. Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction. Front Cardiovasc Med. 2017;4:41doi: 10.3389/fcvm.2017.00041.
Naesgaard, P. A., Grundt, H., Nordøy, A. F., Staines, H., & Nilsen, D. W. T. (2017). Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction. Frontiers in cardiovascular medicine, 441. https://doi.org/10.3389/fcvm.2017.00041
Naesgaard, Patrycja A, et al. "Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction." Frontiers in cardiovascular medicine vol. 4 (2017): 41. doi: https://doi.org/10.3389/fcvm.2017.00041
Naesgaard PA, Grundt H, Nordøy AF, Staines H, Nilsen DWT. Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction. Front Cardiovasc Med. 2017 Jul 24;4:41. doi: 10.3389/fcvm.2017.00041. eCollection 2017. PMID: 28791297; PMCID: PMC5522877.
Copy Download .nbib Format: NLM
Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment.

Frontiers in cardiovascular medicine

Pandya NR, Alphonso N, Tu Q, Venugopal P, Schlapbach LJ.
PMID: 30234130
Front Cardiovasc Med. 2018 Sep 04;5:121. doi: 10.3389/fcvm.2018.00121. eCollection 2018.

Prolonged postoperative vasoplegia is known to occur following cardiac surgery in patients on chronic angiotensin II receptor blocker (ARB) treatment in adults. The perioperative management of these drugs in the pediatric population is not well described and here we...

Cite
Pandya NR, Alphonso N, Tu Q, et al. Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment. Front Cardiovasc Med. 2018;5:121doi: 10.3389/fcvm.2018.00121.
Pandya, N. R., Alphonso, N., Tu, Q., Venugopal, P., & Schlapbach, L. J. (2018). Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment. Frontiers in cardiovascular medicine, 5121. https://doi.org/10.3389/fcvm.2018.00121
Pandya, Nischal R, et al. "Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment." Frontiers in cardiovascular medicine vol. 5 (2018): 121. doi: https://doi.org/10.3389/fcvm.2018.00121
Pandya NR, Alphonso N, Tu Q, Venugopal P, Schlapbach LJ. Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment. Front Cardiovasc Med. 2018 Sep 04;5:121. doi: 10.3389/fcvm.2018.00121. eCollection 2018. PMID: 30234130; PMCID: PMC6131193.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 3295 entries